Search research articles
Contact Us
Filters
Showing results (631-640 of 719) with videos related to
Page
of 72
Sort By:
Science (New York, N.Y.)
|
October 17, 2009
Width and variation of the ENA flux ribbon observed by the Interstellar Boundary Explorer
S A Fuselier, F Allegrini, H O Funsten, et al.
Aging Clinical and Experimental Research
|
May 9, 2016
In-hospital elderly mortality and associated factors in 12 Italian acute medical units: findings from an exploratory longitudinal study
Elisa Ambrosi, Stefano De Togni, Annamaria Guarnier, et al.
Journal of Cardiovascular Development and Disease
|
September 26, 2025
Safety and Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors in Active Cancer Patients with Heart Failure: Results of the Observational TOSCA Trial
Maria Laura Canale, Iacopo Fabiani, Maria Grazia Delle Donne, et al.
Geophysical Research Letters
|
July 22, 2022
Water-Group Pickup Ions From Europa-Genic Neutrals Orbiting Jupiter
J R Szalay, H T Smith, E J Zirnstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2007
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest
Alfredo Falcone, Sergio Ricci, Isa Brunetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2016
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials
C Cremolini, F Loupakis, G Masi, et al.
The Lancet. Oncology
|
September 5, 2015
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
Chiara Cremolini, Fotios Loupakis, Carlotta Antoniotti, et al.
Scandinavian Journal of Caring Sciences
|
May 17, 2017
The degree of satisfaction of in-hospital medical patients with nursing care and predictors of dissatisfaction: findings from a secondary analysis
Alvisa Palese, Silvia Gonella, Anna Fontanive, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 13, 2021
The consequences of a year of the COVID-19 pandemic for the mental health of young adult twins in England and Wales
Kaili Rimfeld, Margherita Malanchini, Ryan Arathimos, et al.
Bjpsych Open
|
July 21, 2022
The consequences of a year of the COVID-19 pandemic for the mental health of young adult twins in England and Wales
Kaili Rimfeld, Margherita Malanchini, Ryan Arathimos, et al.
Page
of 72
Search research articles
Search
Showing results (631-640 of 719) with videos related to
Sort By:
Page
of 72
Science (New York, N.Y.)
|
October 17, 2009
Width and variation of the ENA flux ribbon observed by the Interstellar Boundary Explorer
S A Fuselier, F Allegrini, H O Funsten, et al.
Aging Clinical and Experimental Research
|
May 9, 2016
In-hospital elderly mortality and associated factors in 12 Italian acute medical units: findings from an exploratory longitudinal study
Elisa Ambrosi, Stefano De Togni, Annamaria Guarnier, et al.
Journal of Cardiovascular Development and Disease
|
September 26, 2025
Safety and Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors in Active Cancer Patients with Heart Failure: Results of the Observational TOSCA Trial
Maria Laura Canale, Iacopo Fabiani, Maria Grazia Delle Donne, et al.
Geophysical Research Letters
|
July 22, 2022
Water-Group Pickup Ions From Europa-Genic Neutrals Orbiting Jupiter
J R Szalay, H T Smith, E J Zirnstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2007
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest
Alfredo Falcone, Sergio Ricci, Isa Brunetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2016
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials
C Cremolini, F Loupakis, G Masi, et al.
The Lancet. Oncology
|
September 5, 2015
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
Chiara Cremolini, Fotios Loupakis, Carlotta Antoniotti, et al.
Scandinavian Journal of Caring Sciences
|
May 17, 2017
The degree of satisfaction of in-hospital medical patients with nursing care and predictors of dissatisfaction: findings from a secondary analysis
Alvisa Palese, Silvia Gonella, Anna Fontanive, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 13, 2021
The consequences of a year of the COVID-19 pandemic for the mental health of young adult twins in England and Wales
Kaili Rimfeld, Margherita Malanchini, Ryan Arathimos, et al.
Bjpsych Open
|
July 21, 2022
The consequences of a year of the COVID-19 pandemic for the mental health of young adult twins in England and Wales
Kaili Rimfeld, Margherita Malanchini, Ryan Arathimos, et al.
Page
of 72